Japan’s Mitsubishi Tanabe Pharma to buy Israel’s Neuroderm for $1.1 bln

TOKYO, July 24 (Reuters) – Japan’s Mitsubishi Tanabe PharmaCorp said on Monday it will acquire Israeli drug makerNeuroderm for $1.1 billion in an all-cash deal toexpand its overseas business.
The post Japan’s Mitsubishi Tanabe Pharma to buy Israel’s Neuroderm for $1.1 bln appeared first on RocketNews | Top News Stories From Around the Globe.